Andrea Ellis

CIK: 0001877680

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (41.7%)

Position reduction

Option Exercises (M)5 (41.7%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BBIO

BridgeBio Pharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (12 total)

BBIO
BridgeBio Pharma, Inc.
Jul 9, 2026
Sale(S)
Direct
17.2K shares at avg. $84.00$1.4M
BBIO
BridgeBio Pharma, Inc.
Jul 9, 2026
Exercise(M)
Direct
17.2K shares at avg. $16.75$288K
BBIO
BridgeBio Pharma, Inc.
Jun 22, 2026
Award(A)
Direct
4K shares-
BBIO
BridgeBio Pharma, Inc.
Mar 4, 2026
Sale(S)
Direct
64.9K shares at avg. $64.87$4.2M
BBIO
BridgeBio Pharma, Inc.
Mar 4, 2026
Exercise(M)
Direct
64.9K shares at avg. $8.45$549K
BBIO
BridgeBio Pharma, Inc.
Aug 5, 2025
Exercise(M)
Direct
17.2K shares at avg. $16.75$288K
BBIO
BridgeBio Pharma, Inc.
Aug 5, 2025
Sale(S)
Direct
17.2K shares at avg. $49.00$841K
BBIO
BridgeBio Pharma, Inc.
Jun 20, 2025
Award(A)
Direct
6.6K shares-
BBIO
BridgeBio Pharma, Inc.
Apr 14, 2025
Sale(S)
Direct
10K shares at avg. $35.00$350K
BBIO
BridgeBio Pharma, Inc.
Apr 14, 2025
Exercise(M)
Direct
10K shares at avg. $8.45$85K
BBIO
BridgeBio Pharma, Inc.
Apr 1, 2025
Sale(S)
Direct
30K shares at avg. $34.05$1.0M
BBIO
BridgeBio Pharma, Inc.
Apr 1, 2025
Exercise(M)
Direct
30K shares at avg. $8.45$253K

		Type	Shares	Price		Ownership
Jul 9, 2026	BBIO BridgeBio Pharma, Inc.	Sale(S)	17,167	$84.00	$1,442,028	Direct
Jul 9, 2026	BBIO BridgeBio Pharma, Inc.	Exercise(M)	17,167	$16.75	$287,547	Direct
Jun 22, 2026	BBIO BridgeBio Pharma, Inc.	Award(A)	3,990	-	$0	Direct
Mar 4, 2026	BBIO BridgeBio Pharma, Inc.	Sale(S)	64,921	$64.87	$4,211,302	Direct
Mar 4, 2026	BBIO BridgeBio Pharma, Inc.	Exercise(M)	64,921	$8.45	$548,582	Direct
Aug 5, 2025	BBIO BridgeBio Pharma, Inc.	Exercise(M)	17,167	$16.75	$287,547	Direct
Aug 5, 2025	BBIO BridgeBio Pharma, Inc.	Sale(S)	17,167	$49.00	$841,183	Direct
Jun 20, 2025	BBIO BridgeBio Pharma, Inc.	Award(A)	6,589	-	-	Direct
Apr 14, 2025	BBIO BridgeBio Pharma, Inc.	Sale(S)	10,000	$35.00	$350,000	Direct
Apr 14, 2025	BBIO BridgeBio Pharma, Inc.	Exercise(M)	10,000	$8.45	$84,500	Direct
Apr 1, 2025	BBIO BridgeBio Pharma, Inc.	Sale(S)	30,000	$34.05	$1,021,500	Direct
Apr 1, 2025	BBIO BridgeBio Pharma, Inc.	Exercise(M)	30,000	$8.45	$253,500	Direct

1-12 of 12 transactions

About Ellis Andrea

Ellis Andrea (SEC CIK 0001877680) files insider reports with the SEC as Director of BridgeBio Pharma, Inc. (BBIO).

Signal8 holds 7 ownership filings by Ellis Andrea, all Form 4s, filed between Apr 3, 2025 and Jul 13, 2026. Those filings report 12 transactions, from Apr 1, 2025 to Jul 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ellis Andrea's filings is in PALO ALTO, CA.

Recent filings by Ellis Andrea

Jul 9, 2026: Open-market sale of BBIO shares (Form 4, code S).
Jul 9, 2026: Option exercise of BBIO shares (Form 4, code M).
Jun 22, 2026: Grant or award of BBIO shares (Form 4, code A).
Mar 4, 2026: Open-market sale of BBIO shares (Form 4, code S).
Mar 4, 2026: Option exercise of BBIO shares (Form 4, code M).

Other insiders filing for BridgeBio Pharma, Inc. (BBIO)

Apuli Maricel, Chief Accounting Officer
Kumar Neil, Chief Executive Officer
Trimarchi Thomas, President and CFO
Cook Jennifer E., Director
Valantine Hannah, Director
Lo Andrew, Director

How to read Form 4 transaction codes